Cargando…
Long-term efficacy and safety of tonic motor activation for treatment of medication-refractory restless legs syndrome: A 24-Week Open-Label Extension Study
STUDY OBJECTIVES: To evaluate long-term efficacy and safety of tonic motor activation (TOMAC) for treatment of medication-refractory moderate-to-severe primary restless legs syndrome (RLS). METHODS: In the parent study (RESTFUL), adults with refractory RLS were randomized to active TOMAC or sham for...
Autores principales: | Roy, Asim, Ojile, Joseph, Kram, Jerrold, Olin, Jonathan, Rosenberg, Russell, Hudson, J Douglas, Bogan, Richard K, Charlesworth, Jonathan D |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10566237/ https://www.ncbi.nlm.nih.gov/pubmed/37439365 http://dx.doi.org/10.1093/sleep/zsad188 |
Ejemplares similares
-
Efficacy and safety of tonic motor activation (TOMAC) for medication-refractory restless legs syndrome: a randomized clinical trial
por: Bogan, Richard K, et al.
Publicado: (2023) -
Adjunctive tonic motor activation enables opioid reduction for refractory restless legs syndrome: a prospective, open-label, single-arm clinical trial
por: Buchfuhrer, Mark J., et al.
Publicado: (2023) -
Striatal histamine mechanism in the pathogenesis of restless legs syndrome
por: Lai, Yuan-Yang, et al.
Publicado: (2019) -
Factors associated with augmentation in patients with restless legs syndrome
por: Heim, Beatrice, et al.
Publicado: (2021) -
High national rates of high-dose dopamine agonist prescribing for restless legs syndrome
por: Winkelman, John W
Publicado: (2021)